[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Müller-Eberhard, 1985 - Google Patents

The killer molecule of complement

Müller-Eberhard, 1985

View PDF
Document ID
5186003318281282915
Author
Müller-Eberhard H
Publication year
Publication venue
Journal of Investigative Dermatology

External Links

Snippet

Cell injury by complement occurs as a consequence of activation of either the classical or the alternative pathway on the surface of a cell. It is accomplished by the membrane attack complex (MAC). Its precursor proteins, C5, C6, C7, C8, and C9, are hydrophilic …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Müller-Eberhard The killer molecule of complement
Podack et al. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly
Hartgers et al. DC‐STAMP, a novel multimembrane‐spanning molecule preferentially expressed by dendritic cells
DE69533295T3 (en) Melanoma-associated antigens, epitopes thereof and melanoma-containing vaccines
US7659252B2 (en) Transdermal delivery peptides and method of use thereof
JP2008029344A (en) Novel compound
MX2007009219A (en) Survivin peptide vaccine.
US6172201B1 (en) Cellular receptor for HIV-1 Vpr essential for G2/M phase
CN109890411A (en) Tuberculosis composition and treatment or prevention method lungy
WO2014059384A2 (en) ICAM-1 TARGETING ELPs
US6235285B1 (en) Glycogen phosphorylase from streptococcus pneumoniae
JP2004000215A (en) New topoisomerase iii
DE69624586T2 (en) PEPTIDE VACCINE BASED ON FUSION PROTEINS WITH ONCOGENIC PART
CN109970865A (en) A kind of two-way activation costimulatory molecules receptor of CD137 and application thereof
US20220195401A1 (en) Modified piggybac transposase polypeptide, polynucleotide encoding them, introducing carrier, kit, method of incorporating target sequence into cell genome, and method of producing cell
JP4065322B2 (en) Synthetic peptides and pharmaceutical compositions containing them
JPH10309194A (en) Topoisomerase i
CA2991223A1 (en) Pore-forming peptides and uses thereof
CN100480387C (en) GBS toxin receptor
CA2244232A1 (en) Novel def
KR20230156367A (en) A pharmaceutical composition and the use thereof in the treatment of autoimmune diseases
JP2001515363A (en) Staphylococcus aureus UDP-N-acetylmuramoyl-L-alanine: D-glutamme Triggerase (murD)
CA2244239A1 (en) Novel era
US20060270605A1 (en) Compositions and methods for inhibiting cell growth and modulating gene expression
US20230364261A1 (en) Targeted antigen delivery system and uses thereof